# Study of INV-102 Ophthalmic Solution in Adults With Acute Infectious Keratoconjunctivitis

> **NCT05636228** · PHASE2 · COMPLETED · sponsor: **Invirsa, Inc.** · enrollment: 93 (actual)

## Conditions studied

- Acute Infectious Keratoconjunctivitis

## Interventions

- **DRUG:** INV-102
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT05636228
- **Lead sponsor:** Invirsa, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-09
- **Primary completion:** 2024-08-22
- **Final completion:** 2024-08-22
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2025-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05636228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05636228, "Study of INV-102 Ophthalmic Solution in Adults With Acute Infectious Keratoconjunctivitis". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05636228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*